Franklyn G Prendergast is Director of Vyant Bio, Inc.. Currently has a direct ownership of 12,500 shares of VYNT, which is worth approximately $0. The most recent transaction as insider was on Sep 28, 2017, when has been sold 2,500 shares (Common Stock, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.5K
0% 3M change
0% 12M change
Total Value Held $0

FRANKLYN G PRENDERGAST Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 28 2017
BUY
Grant, award, or other acquisition
-
2,500 Added 16.67%
12,500 Common Stock, par valu...
Jun 07 2017
BUY
Grant, award, or other acquisition
-
2,500 Added 20.0%
10,000 Common Stock, par valu...
Oct 11 2016
BUY
Grant, award, or other acquisition
-
2,500 Added 25.0%
7,500 Common Stock, par valu...
May 22 2014
BUY
Grant, award, or other acquisition
-
5,000 Added 50.0%
5,000 Common Stock, par valu...

Also insider at

LLY
ELI LILLY & Co Healthcare
IMNM
Immunome Inc. Healthcare
NBSE
NeuBase Therapeutics, Inc. Healthcare
LTRN
Lantern Pharma Inc. Healthcare
FGP

Franklyn G Prendergast

Director
Rutherford, NJ

Track Institutional and Insider Activities on VYNT

Follow Vyant Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYNT shares.

Notify only if

Insider Trading

Get notified when an Vyant Bio, Inc. insider buys or sells VYNT shares.

Notify only if

News

Receive news related to Vyant Bio, Inc.

Track Activities on VYNT